Sitemap
January 29, 2007 Articles
Filter by Available Specialty
- Bioptigen receives FDA premarket approval for new OCT system
- Differences in low-vision questionnaire administration can affect scores
- Genentech letter: Increased stroke risk with 0.5-mg dose in Lucentis SAILOR study
- New RA drug shows efficacy over methotrexate alone in phase 3 trial
- Study finds high risk of pseudoexfoliation syndrome converting to glaucoma